Exenatide
Also known as Byetta, Bydureon
Exenatide (Byetta/Bydureon) was one of the first GLP-1 diabetes injections — it lowers blood sugar and curbs appetite. The original is twice-daily; the extended-release version is weekly.
How one dose clears
modeled over ~6 half-lives- Half-life
- 2.4 h
- Time to peak (Tmax)
- 2.1 h
- Bioavailability
- 65%
- Steady state
- ~1 days
- Typical dose
- 5 mcg
Short-acting GLP-1 receptor agonist (Byetta, twice daily). Bydureon is an extended-release weekly form with very different PK.
Mechanism of action
Exendin-4 analog; GLP-1 receptor agonist resistant to DPP-4.
Byetta PK shown here; the Bydureon microsphere formulation behaves completely differently.
References
Track Exenatide for free
Log your doses and PeptideBuddy models Exenatide's half-life into a live chart so you always know how much is active — plus reminders, reconstitution and protocol planning.
Start tracking freeFree. No card required.